Epidarex Exeed
epidarex-exeed.com
Actively hiring
Precision Medicine
Health Care
Medical AI
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Epidarex Capital
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Epidarex Capital Similar startupsby what they do, their industry and backers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and…
About Science & Services Mission Vision Value Team Company Science & Services Science…
Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience…
Velsera is a leading provider of omics analytics solutions, powering precision medicine and enhancing the healthcare and life sciences…
AI Research Research Overview Causality Representation Learning Survival Analysis Ataraxis Breast Ataraxis Breast Overview Recurrence Risk…
Mindpeak transforms tissue into high-dimensional data, enabling the discovery of AI-driven biomarkers that guide targeted therapies and…
Overview
We seed early stage and highly innovative life sciences assets to create companies based on breakthrough assets.
News
Epidarex Exeed first spin-out company, Lario Therapeutics, receives "Company Making a Difference Award" from CDLK5 Forum, recognising its unique approach to precision medicine for genetic epilepsies
"CDLK5 Forum Award for Excellence - Company Making a Difference 2023 Pre-clinical" presented by the Loulou Foundation at the CDKL5 Forum, 6th-7th November in London First-in-class ion channel inhibitors show promise as anti-seizure therapeutics for multip
Read more
Report
Epidarex Exeed founded by Epidarex Capital to advance early stage, highly innovative life science assets
Epidarex's therapeutic discovery engine will identify innovative early stage assets, providing hands-on scientific support and funding to drive drug discovery projects Exeed will mould and de-risk opportunities, making them ready for company creation and
Read more
Report